Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Vaccines

  Free Subscription


Articles published in Proc Natl Acad Sci U S A

Retrieve available abstracts of 65 articles:
HTML format



Single Articles


    November 2022
  1. MCMAHON M, O'Dell G, Tan J, Sarkozy A, et al
    Assessment of a quadrivalent nucleoside-modified mRNA vaccine that protects against group 2 influenza viruses.
    Proc Natl Acad Sci U S A. 2022;119:e2206333119.
    PubMed     Abstract available


    October 2022
  2. YANG K, Wang C, Kreutzberger AJB, Ojha R, et al
    Nanomolar inhibition of SARS-CoV-2 infection by an unmodified peptide targeting the prehairpin intermediate of the spike protein.
    Proc Natl Acad Sci U S A. 2022;119:e2210990119.
    PubMed     Abstract available


    September 2022
  3. VAN BEEK M, Nussenzweig MC, Chakraborty AK
    Two complementary features of humoral immune memory confer protection against the same or variant antigens.
    Proc Natl Acad Sci U S A. 2022;119:e2205598119.
    PubMed     Abstract available


    August 2022
  4. LU M, Chamblee M, Zhang Y, Ye C, et al
    SARS-CoV-2 prefusion spike protein stabilized by six rather than two prolines is more potent for inducing antibodies that neutralize viral variants of concern.
    Proc Natl Acad Sci U S A. 2022;119:e2110105119.
    PubMed     Abstract available


  5. YANG Z, Wu D, Lu S, Qiu Y, et al
    Plasma metabolome and cytokine profile reveal glycylproline modulating antibody fading in convalescent COVID-19 patients.
    Proc Natl Acad Sci U S A. 2022;119:e2117089119.
    PubMed     Abstract available


  6. XIONG H, Sun H, Wang S, Yuan L, et al
    The neutralizing breadth of antibodies targeting diverse conserved epitopes between SARS-CoV and SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2022;119:e2204256119.
    PubMed     Abstract available


  7. CHEN J, Ye Z, Huang C, Qiu M, et al
    Lipid nanoparticle-mediated lymph node-targeting delivery of mRNA cancer vaccine elicits robust CD8(+) T cell response.
    Proc Natl Acad Sci U S A. 2022;119:e2207841119.
    PubMed     Abstract available


  8. ZHANG Y, Lu M, Mahesh KC, Kim E, et al
    A highly efficacious live attenuated mumps virus-based SARS-CoV-2 vaccine candidate expressing a six-proline stabilized prefusion spike.
    Proc Natl Acad Sci U S A. 2022;119:e2201616119.
    PubMed     Abstract available


  9. BACKLUND CM, Holden RL, Moynihan KD, Garafola D, et al
    Cell-penetrating peptides enhance peptide vaccine accumulation and persistence in lymph nodes to drive immunogenicity.
    Proc Natl Acad Sci U S A. 2022;119:e2204078119.
    PubMed     Abstract available


  10. TOWNSEND JP, Hassler HB, Sah P, Galvani AP, et al
    The durability of natural infection and vaccine-induced immunity against future infection by SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2022;119:e2204336119.
    PubMed     Abstract available


    July 2022
  11. RABB N, Bowers J, Glick D, Wilson KH, et al
    The influence of social norms varies with "others" groups: Evidence from COVID-19 vaccination intentions.
    Proc Natl Acad Sci U S A. 2022;119:e2118770119.
    PubMed     Abstract available


  12. KARDAVA L, Rachmaninoff N, Lau WW, Buckner CM, et al
    Early human B cell signatures of the primary antibody response to mRNA vaccination.
    Proc Natl Acad Sci U S A. 2022;119:e2204607119.
    PubMed     Abstract available


    June 2022
  13. SIEWERT LK, Korotaev A, Sedzicki J, Fromm K, et al
    Identification of the Bartonella autotransporter CFA as a protective antigen and hypervariable target of neutralizing antibodies in mice.
    Proc Natl Acad Sci U S A. 2022;119:e2202059119.
    PubMed     Abstract available


  14. AMERICO JL, Cotter CA, Earl PL, Liu R, et al
    Intranasal inoculation of an MVA-based vaccine induces IgA and protects the respiratory tract of hACE2 mice from SARS-CoV-2 infection.
    Proc Natl Acad Sci U S A. 2022;119:e2202069119.
    PubMed     Abstract available


  15. OTIANG E, Yoder J, Manian S, Campbell ZA, et al
    Vaccination of household chickens results in a shift in young children's diet and improves child growth in rural Kenya.
    Proc Natl Acad Sci U S A. 2022;119:e2122389119.
    PubMed     Abstract available


  16. NARCISO AR, Iovino F, Thorsdottir S, Mellroth P, et al
    Membrane particles evoke a serotype-independent cross-protection against pneumococcal infection that is dependent on the conserved lipoproteins MalX and PrsA.
    Proc Natl Acad Sci U S A. 2022;119:e2122386119.
    PubMed     Abstract available


    May 2022
  17. HEKMATI A, Luhar M, Krishnamachari B, Mataric M, et al
    Simulating COVID-19 classroom transmission on a university campus.
    Proc Natl Acad Sci U S A. 2022;119:e2116165119.
    PubMed     Abstract available


  18. BAXTER-KING R, Brown JR, Enos RD, Naeim A, et al
    How local partisan context conditions prosocial behaviors: Mask wearing during COVID-19.
    Proc Natl Acad Sci U S A. 2022;119:e2116311119.
    PubMed     Abstract available


  19. ZHU X, Han J, Sun W, Puente-Massaguer E, et al
    Influenza chimeric hemagglutinin structures in complex with broadly protective antibodies to the stem and trimer interface.
    Proc Natl Acad Sci U S A. 2022;119:e2200821119.
    PubMed     Abstract available


  20. KINGSTAD-BAKKE B, Lee W, Chandrasekar SS, Gasper DJ, et al
    Vaccine-induced systemic and mucosal T cell immunity to SARS-CoV-2 viral variants.
    Proc Natl Acad Sci U S A. 2022;119:e2118312119.
    PubMed     Abstract available


  21. SPRECO A, Schon T, Timpka T
    Corruption should be taken into account when considering COVID-19 vaccine allocation.
    Proc Natl Acad Sci U S A. 2022;119:e2122664119.
    PubMed    


  22. DUCH R, Robinson TS, Clarke PM, Roope LSJ, et al
    Reply to Spreco et al.: Perceived corruption and preferences for COVID-19 vaccine allocations.
    Proc Natl Acad Sci U S A. 2022;119:e2201847119.
    PubMed    


    April 2022
  23. POSTIGO-FERNANDEZ J, Firdessa-Fite R, Creusot RJ
    Preclinical evaluation of a precision medicine approach to DNA vaccination in type 1 diabetes.
    Proc Natl Acad Sci U S A. 2022;119:e2110987119.
    PubMed     Abstract available


  24. ROBINSON PC, Liew DFL, Tanner HL, Grainger JR, et al
    COVID-19 therapeutics: Challenges and directions for the future.
    Proc Natl Acad Sci U S A. 2022;119:e2119893119.
    PubMed     Abstract available


  25. TEPLENSKY MH, Distler ME, Kusmierz CD, Evangelopoulos M, et al
    Spherical nucleic acids as an infectious disease vaccine platform.
    Proc Natl Acad Sci U S A. 2022;119:e2119093119.
    PubMed     Abstract available


    March 2022
  26. KAVISHNA R, Kang TY, Vacca M, Chua BYL, et al
    A single-shot vaccine approach for the universal influenza A vaccine candidate M2e.
    Proc Natl Acad Sci U S A. 2022;119:e2025607119.
    PubMed     Abstract available


  27. SCHMELZ K, Bowles S
    Opposition to voluntary and mandated COVID-19 vaccination as a dynamic process: Evidence and policy implications of changing beliefs.
    Proc Natl Acad Sci U S A. 2022;119:e2118721119.
    PubMed     Abstract available


  28. FOSTER SL, Woolsey C, Borisevich V, Agans KN, et al
    A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against lethal Nipah virus disease.
    Proc Natl Acad Sci U S A. 2022;119:e2200065119.
    PubMed     Abstract available


  29. LEWNARD JA, Fries LF, Cho I, Chen J, et al
    Prevention of antimicrobial prescribing among infants following maternal vaccination against respiratory syncytial virus.
    Proc Natl Acad Sci U S A. 2022;119:e2112410119.
    PubMed     Abstract available


  30. WANG X, Li P, Singh AK, Zhang X, et al
    Remodeling Yersinia pseudotuberculosis to generate a highly immunogenic outer membrane vesicle vaccine against pneumonic plague.
    Proc Natl Acad Sci U S A. 2022;119:e2109667119.
    PubMed     Abstract available


  31. WANG R, Suzuki S, Guest JD, Heller B, et al
    Induction of broadly neutralizing antibodies using a secreted form of the hepatitis C virus E1E2 heterodimer as a vaccine candidate.
    Proc Natl Acad Sci U S A. 2022;119:e2112008119.
    PubMed     Abstract available


  32. SHAN S, Luo S, Yang Z, Hong J, et al
    Deep learning guided optimization of human antibody against SARS-CoV-2 variants with broad neutralization.
    Proc Natl Acad Sci U S A. 2022;119:e2122954119.
    PubMed     Abstract available


  33. WU CY, Cheng CW, Kung CC, Liao KS, et al
    Glycosite-deleted mRNA of SARS-CoV-2 spike protein as a broad-spectrum vaccine.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  34. PETERSEN GEL, Buntjer JB, Hely FS, Byrne TJ, et al
    Modeling suggests gene editing combined with vaccination could eliminate a persistent disease in livestock.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


    February 2022
  35. WIECEK W, Ahuja A, Chaudhuri E, Kremer M, et al
    Testing fractional doses of COVID-19 vaccines.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  36. DEVARAJAN P, Vong AM, Castonguay CH, Kugler-Umana O, et al
    Strong influenza-induced TFH generation requires CD4 effectors to recognize antigen locally and receive signals from continuing infection.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  37. HOFF NA, Bratcher A, Kelly JD, Musene K, et al
    Immunogenicity of rVSVDeltaG-ZEBOV-GP Ebola vaccination in exposed and potentially exposed persons in the Democratic Republic of the Congo.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  38. MILKMAN KL, Gandhi L, Patel MS, Graci HN, et al
    A 680,000-person megastudy of nudges to encourage vaccination in pharmacies.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  39. MILDER FJ, Jongeneelen M, Ritschel T, Bouchier P, et al
    Universal stabilization of the influenza hemagglutinin by structure-based redesign of the pH switch regions.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  40. BEANS C
    Researchers getting closer to a "universal" flu vaccine.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed    


    January 2022
  41. VARRELMAN TJ, Remien CH, Basinski AJ, Gorman S, et al
    Quantifying the effectiveness of betaherpesvirus-vectored transmissible vaccines.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  42. GANDON S, Lion S
    Targeted vaccination and the speed of SARS-CoV-2 adaptation.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


  43. HUPERT N, Marin-Hernandez D, Gao B, Aguas R, et al
    Heterologous vaccination interventions to reduce pandemic morbidity and mortality: Modeling the US winter 2020 COVID-19 wave.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


    December 2021
  44. SHAFFER L
    Inner Workings: Using vaccines to harness the immune system and fight drugs of abuse.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  45. JAMIESON KH, Romer D, Jamieson PE, Winneg KM, et al
    The role of non-COVID-specific and COVID-specific factors in predicting a shift in willingness to vaccinate: A panel study.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  46. SALOMON JA, Reinhart A, Bilinski A, Chua EJ, et al
    The US COVID-19 Trends and Impact Survey: Continuous real-time measurement of COVID-19 symptoms, risks, protective behaviors, testing, and vaccination.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  47. NAIR P
    QnAs with Katalin Kariko.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  48. LIU X, Luongo C, Matsuoka Y, Park HS, et al
    A single intranasal dose of a live-attenuated parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in hamsters.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  49. CHU J, Pink SL, Willer R
    Religious identity cues increase vaccination intentions and trust in medical experts among American Christians.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  50. BOKEMPER SE, Gerber AS, Omer SB, Huber GA, et al
    Persuading US White evangelicals to vaccinate for COVID-19: Testing message effectiveness in fall 2020 and spring 2021.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    November 2021
  51. NARR K, Ertuna YI, Fallet B, Cornille K, et al
    Vaccine-elicited CD4 T cells prevent the deletion of antiviral B cells in chronic infection.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  52. ADAM D
    News Feature: Biology research, no cells required: By borrowing the machinery of life from broken cells, researchers are producing novel proteins, cheap lab reagents, and just-add-water vaccines.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  53. PEDERSON T
    A layperson encounter, on the "modified" RNA world.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  54. XIA D, Jin R, Byagathvalli G, Yu H, et al
    An ultra-low-cost electroporator with microneedle electrodes (ePatch) for SARS-CoV-2 vaccination.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  55. PISHESHA N, Harmand TJ, Rothlauf PW, Praest P, et al
    A class II MHC-targeted vaccine elicits immunity against SARS-CoV-2 and its variants.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    October 2021
  56. GUTIERREZ-ALVAREZ J, Honrubia JM, Sanz-Bravo A, Gonzalez-Miranda E, et al
    Middle East respiratory syndrome coronavirus vaccine based on a propagation-defective RNA replicon elicited sterilizing immunity in mice.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  57. HUGHES MT, Auwaerter PG, Ehmann MR, Garibaldi BT, et al
    Opinion: The importance of offering vaccine choice in the fight against COVID-19.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  58. HENSEN L, Nguyen THO, Rowntree LC, Damelang T, et al
    Robust and prototypical immune responses toward influenza vaccines in the high-risk group of Indigenous Australians.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  59. GARCIA-SASTRE A
    Genomics serology to inform therapies and vaccines for arthritogenic alphaviruses.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


    September 2021
  60. XU S, McGinnis KR, Liu Y, Huang P, et al
    Structural basis of P[II] rotavirus evolution and host ranges under selection of histo-blood group antigens.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    August 2021
  61. KAUGARS K, Dardick J, de Oliveira AP, Weiss KA, et al
    A recombinant herpes virus expressing influenza hemagglutinin confers protection and induces antibody-dependent cellular cytotoxicity.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    May 2021
  62. MCDERMOTT A
    Core Concept: Herd immunity is an important-and often misunderstood-public health phenomenon.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  63. LABUDA JC, Pham OH, Depew CE, Fong KD, et al
    Circulating immunity protects the female reproductive tract from Chlamydia infection.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    April 2021
  64. LIN X, Twelkmeyer T, Zhu D, Zhang L, et al
    Homeostatic regulation of T follicular helper and antibody response to particle antigens by IL-1Ra of medullary sinus macrophage origin.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    March 2021
  65. LE NOUEN C, McCarty T, Yang L, Brown M, et al
    Rescue of codon-pair deoptimized respiratory syncytial virus by the emergence of genomes with very large internal deletions that complemented replication.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: